Gossamer Bio, Inc. — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Gossamer Bio filed an 8-K on September 28, 2026 for period ending September 25, 2026, disclosing other events under Item 8.01. The specific content of the event is not accessible in the provided filing metadata; only the form structure, document references, and company information (San Diego, CA headquarters; CIK 0001728117) are present.
Why this rating
Item 8.01 is a catch-all for non-material events; actual content unavailable in metadata stub. Cannot assess business impact without disclosed details.
Extracted items
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.